Excellent option for mass testing during the SARS-CoV-2 pandemic: painless self-collection and direct RT-qPCR
- PMID: 33947425
- PMCID: PMC8094981
- DOI: 10.1186/s12985-021-01567-3
Excellent option for mass testing during the SARS-CoV-2 pandemic: painless self-collection and direct RT-qPCR
Abstract
The early identification of asymptomatic yet infectious cases is vital to curb the 2019 coronavirus (COVID-19) pandemic and to control the disease in the post-pandemic era. In this paper, we propose a fast, inexpensive and high-throughput approach using painless nasal-swab self-collection followed by direct RT-qPCR for the sensitive PCR detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This approach was validated in a large prospective cohort study of 1038 subjects, analysed simultaneously using (1) nasopharyngeal swabs obtained with the assistance of healthcare personnel and analysed by classic two-step RT-qPCR on RNA isolates and (2) nasal swabs obtained by self-collection and analysed with direct RT-qPCR. Of these subjects, 28.6% tested positive for SARS-CoV-2 using nasopharyngeal swab sampling. Our direct RT-qPCR approach for self-collected nasal swabs performed well with results similar to those of the two-step RT-qPCR on RNA isolates, achieving 0.99 positive and 0.98 negative predictive values (cycle threshold [Ct] < 37). Our research also reports on grey-zone viraemia, including samples with near-cut-off Ct values (Ct ≥ 37). In all investigated subjects (n = 20) with grey-zone viraemia, the ultra-small viral load disappeared within hours or days with no symptoms. Overall, this study underscores the importance of painless nasal-swab self-collection and direct RT-qPCR for mass testing during the SARS-CoV-2 pandemic and in the post-pandemic era.
Keywords: COVID-19; Mass molecular testing; Nasal mid-turbinate swab; PCR diagnostics; Post-pandemic era; Self-collection.
Conflict of interest statement
E.K., R.F., M.R., P.Sa., J.M., M.D., O.J., P.St., M.K. have no conflict of interest, P.K. is member of the board of directors of a company Institute of Applied Biotechnologies a.s. The funders and the company had no role in the design, execution, interpretation, or writing of the study.
Figures
References
-
- Al-Rifai RH, Acuna J, Al Hossany FI, Aden B, Al Memari SA, Al Mazrouei SK, Ahmed LA. Epidemiological characterization of symptomatic and asymptomatic COVID-19 cases and positivity in subsequent RT-PCR tests in the United Arab Emirates. PLoS ONE. 2021;16:e0246903. doi: 10.1371/journal.pone.0246903. - DOI - PMC - PubMed
-
- Buitrago-Garcia D, Egli-Gany D, Counotte MJ, Hossmann S, Imeri H, Ipekci AM, Salanti G, Low N. Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: a living systematic review and meta-analysis. PLoS Med. 2020;17:e1003346. doi: 10.1371/journal.pmed.1003346. - DOI - PMC - PubMed
-
- Byambasuren O, Cardona M, Bell K, Clark J, McLaws M-L, Glasziou P. Estimating the extent of asymptomatic COVID-19 and its potential for community transmission: systematic review and meta-analysis. J Assoc Med Microbiol Infect Dis Canada. 2020;5:223–234. doi: 10.3138/jammi-2020-0030. - DOI - PMC - PubMed
-
- CDC, 2020. Interim guidelines for collecting, handling, and testing clinical specimens for COVID-19. https://www.cdc.gov/coronavirus/2019-ncov/lab/guidelines-clinical-specim.... Accessed on 16 March 2021.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
